An overview of chondrosarcoma with a focus on nanoscale therapeutics
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Pharmaceutical Investigation"
DOI: 10.1007/s40005-020-00492-x
Abstract: Chondrosarcoma (CHS) is the second most common sarcoma. However, pathogenesis and etiology of this malignant tumor are still unclear. The primary treatment method for CHS is surgery, and CHS is often resistant to conventional chemotherapy.… read more here.
Keywords: treatment; nanoscale therapeutics; overview chondrosarcoma; focus nanoscale ... See more keywords